Literature DB >> 8214006

Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture.

G K Wollenberg1, L E DeForge, G Bolgos, D G Remick.   

Abstract

To investigate the differences in cytokine regulation in vitro as compared to in vivo, we examined the synthesis of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by peritoneal macrophages in response to lipopolysaccharide (LPS). Mice (CBA/J) were primed with an intraperitoneal injection of complete Freund's adjuvant and after 2 weeks, peritoneal cells were harvested for culture or mice were injected intraperitoneally with LPS for in vivo studies. In ascites fluid, TNF-alpha peaked 1 hour after LPS and returned to baseline levels by 4 hours. In contrast, TNF-alpha in the media reached maximum at 7 hours. Expression of TNF-alpha messenger (m)RNA in vivo was rapid but transient, as levels peaked at 15 minutes and returned to baseline 1 hour after LPS. In contrast, TNF-alpha mRNA in vitro became maximal at 1 hour, but remained elevated to 5 hours after LPS. In vivo, IL-6 in ascites fluid peaked at 2 hours, whereas in vitro, IL-6 continued increasing to 24 hours. In vivo, IL-6 mRNA reached maximum at 30 minutes, but fell below baseline by 1.5 hours after LPS. In contrast, IL-6 mRNA in vitro was sustained at maximal expression between 5 to 9 hours after LPS. These results demonstrate that both TNF-alpha and IL-6 synthesis is more rapid in vivo than in vitro. The rapid kinetics of cytokine expression in vivo must considered when designing strategies to inhibit cytokine action in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214006      PMCID: PMC1887059     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

Review 1.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

2.  Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA.

Authors:  K Tokunaga; H Taniguchi; K Yoda; M Shimizu; S Sakiyama
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

3.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

4.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

5.  Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.

Authors:  D Pennica; J S Hayflick; T S Bringman; M A Palladino; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

6.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

7.  Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients.

Authors:  A Waage; T Espevik; J Lamvik
Journal:  Scand J Immunol       Date:  1986-12       Impact factor: 3.487

8.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

9.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Authors:  B A Beutler; I W Milsark; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Connective tissue proteins and phagocytic cell function. Laminin enhances complement and Fc-mediated phagocytosis by cultured human macrophages.

Authors:  J F Bohnsack; H K Kleinman; T Takahashi; J J O'Shea; E J Brown
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  17 in total

1.  Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan.

Authors:  J Soltys; M T Quinn
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment.

Authors:  D R Call; J A Nemzek; S J Ebong; G L Bolgos; D E Newcomb; D G Remick
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Identification and characterization of a novel anti-inflammatory lipid isolated from Mycobacterium vaccae, a soil-derived bacterium with immunoregulatory and stress resilience properties.

Authors:  David G Smith; Roberta Martinelli; Gurdyal S Besra; Petr A Illarionov; Istvan Szatmari; Peter Brazda; Mary A Allen; Wenqing Xu; Xiang Wang; László Nagy; Robin D Dowell; Graham A W Rook; Laura Rosa Brunet; Christopher A Lowry
Journal:  Psychopharmacology (Berl)       Date:  2019-05-22       Impact factor: 4.530

Review 4.  The net immunologic advantage of laparoscopic surgery.

Authors:  Y W Novitsky; D E M Litwin; M P Callery
Journal:  Surg Endosc       Date:  2004-08-26       Impact factor: 4.584

5.  Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis.

Authors:  Albert Dahdah; Gregory Gautier; Tarik Attout; Frédéric Fiore; Emeline Lebourdais; Rasha Msallam; Marc Daëron; Renato C Monteiro; Marc Benhamou; Nicolas Charles; Jean Davoust; Ulrich Blank; Bernard Malissen; Pierre Launay
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

6.  Dynamic production of tumour necrosis factor-alpha (TNF-alpha) messenger RNA, intracellular and extracellular TNF-alpha by murine macrophages and possible association with protein tyrosine phosphorylation of STAT1 alpha and ERK2 as an early signal.

Authors:  Z M Zheng; S Specter
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

Review 7.  Tumor necrosis factor inhibitors for the treatment of asthma.

Authors:  Jiyoun Kim; Daniel G Remick
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

8.  Functional and morphological effects of tumour necrosis factor alpha in an interleukin 6-producing pulmonary large cell carcinoma with sarcomatoid features.

Authors:  T Motoyama; H Watanabe; T Kumanishi; H Usui; H Hashimoto; T Hachisu; I Fukamachi; T Arai; K Takehara
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Acute pulmonary lipopolysaccharide tolerance decreases TNF-alpha without reducing neutrophil recruitment.

Authors:  Sudha Natarajan; Jiyoun Kim; Daniel G Remick
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

10.  Immunological priming attenuates the in vivo pathophysiological response to lipopolysaccharide. Comparison of cytokine production, tissue injury, and lethality in complete Freund's adjuvant-primed mice and in unprimed mice.

Authors:  L E DeForge; E Takeuchi; D T Nguyen; D G Remick
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.